Bertrand Le Bourdonnec

1.6k total citations
38 papers, 1.0k citations indexed

About

Bertrand Le Bourdonnec is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Bertrand Le Bourdonnec has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 10 papers in Organic Chemistry. Recurrent topics in Bertrand Le Bourdonnec's work include Neuropeptides and Animal Physiology (13 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (11 papers). Bertrand Le Bourdonnec is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (11 papers). Bertrand Le Bourdonnec collaborates with scholars based in United States, France and Belgium. Bertrand Le Bourdonnec's co-authors include Roland E. Dolle, Guillermo A. Morales, Catherine Goodman, Craig J. Thomas, Joseph M. Salvino, Wei Zhang, K.J.M. Moriarty, Robert N. DeHaven, Patrick Little and Karin Worm and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Bertrand Le Bourdonnec

36 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertrand Le Bourdonnec United States 16 511 489 255 105 97 38 1.0k
Benjamin E. Blass United States 17 468 0.9× 368 0.8× 115 0.5× 51 0.5× 96 1.0× 80 978
Gregor J. Macdonald Belgium 25 698 1.4× 607 1.2× 325 1.3× 33 0.3× 125 1.3× 62 1.5k
José Ignacio Andrés Belgium 18 342 0.7× 394 0.8× 232 0.9× 50 0.5× 134 1.4× 42 895
Mario Giannella Italy 20 329 0.6× 560 1.1× 371 1.5× 32 0.3× 97 1.0× 59 931
Hartmut E. Greiner Germany 17 234 0.5× 394 0.8× 314 1.2× 40 0.4× 89 0.9× 32 839
Andrew W. Stamford United States 22 479 0.9× 604 1.2× 245 1.0× 127 1.2× 171 1.8× 51 1.5k
Methvin Isaac Canada 20 543 1.1× 604 1.2× 251 1.0× 57 0.5× 57 0.6× 42 1.2k
Kazumi Shiosaki United States 18 470 0.9× 480 1.0× 313 1.2× 167 1.6× 220 2.3× 37 1.2k
Kevin J. Hodgetts United States 16 353 0.7× 275 0.6× 134 0.5× 45 0.4× 95 1.0× 32 769
О.А. Бунеева Russia 18 128 0.3× 610 1.2× 162 0.6× 202 1.9× 108 1.1× 90 1.0k

Countries citing papers authored by Bertrand Le Bourdonnec

Since Specialization
Citations

This map shows the geographic impact of Bertrand Le Bourdonnec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Le Bourdonnec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Le Bourdonnec more than expected).

Fields of papers citing papers by Bertrand Le Bourdonnec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Le Bourdonnec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Le Bourdonnec. The network helps show where Bertrand Le Bourdonnec may publish in the future.

Co-authorship network of co-authors of Bertrand Le Bourdonnec

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Le Bourdonnec. A scholar is included among the top collaborators of Bertrand Le Bourdonnec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Le Bourdonnec. Bertrand Le Bourdonnec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Caldwell, Timothy M., Yu Mi Ahn, Stacie L. Bulfer, et al.. (2022). Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT). Bioorganic & Medicinal Chemistry Letters. 74. 128928–128928. 19 indexed citations
3.
Tardiff, Daniel F., Matthew C. Lucas, Iwona Wrona, et al.. (2022). Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease. Molecular Neurobiology. 59(4). 2171–2189. 18 indexed citations
4.
Caldwell, Timothy M., Michael D. Kaufman, Scott Wise, et al.. (2022). Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 74. 128929–128929. 7 indexed citations
5.
Vincent, Benjamin, Daniel F. Tardiff, Jeff S. Piotrowski, et al.. (2018). Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity. Cell Reports. 25(10). 2742–2754.e31. 102 indexed citations
6.
Nozaki, Chihiro, Bertrand Le Bourdonnec, David J. Reiss, et al.. (2012). δ-Opioid Mechanisms for ADL5747 and ADL5859 Effects in Mice: Analgesia, Locomotion, and Receptor Internalization. Journal of Pharmacology and Experimental Therapeutics. 342(3). 799–807. 64 indexed citations
7.
Chu, Guo‐Hua, Bertrand Le Bourdonnec, Minghua Gu, et al.. (2009). Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors. PubMed. 3(1). 8–13. 8 indexed citations
8.
Bourdonnec, Bertrand Le, Karin Worm, Catherine Goodman, et al.. (2009). Novel sulfamoyl benzamides as selective CB2 agonists with improved in vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters. 20(1). 387–391. 9 indexed citations
9.
Chu, Guo‐Hua, Christopher T. Saeui, Karin Worm, et al.. (2009). Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(20). 5931–5935. 12 indexed citations
10.
Goodman, Catherine, Karin Worm, Bertrand Le Bourdonnec, et al.. (2008). CB2 selective sulfamoyl benzamides: Optimization of the amide functionality. Bioorganic & Medicinal Chemistry Letters. 19(2). 309–313. 14 indexed citations
11.
Goodman, Catherine, Bertrand Le Bourdonnec, & Roland E. Dolle. (2007). Mu Opioid Receptor Antagonists: Recent Developments. ChemMedChem. 2(11). 1552–1570. 60 indexed citations
12.
Bourdonnec, Bertrand Le, Lara K. Leister, Joel Cassel, et al.. (2007). Discovery of a series of aminopiperidines as novel iNOS inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 336–343. 9 indexed citations
13.
Dolle, Roland E., Bertrand Le Bourdonnec, Guillermo A. Morales, K.J.M. Moriarty, & Joseph M. Salvino. (2006). Comprehensive Survey of Combinatorial Library Synthesis:  2005. Journal of Combinatorial Chemistry. 8(5). 597–635. 136 indexed citations
14.
Bourdonnec, Bertrand Le, Roberta Susnow, Joel Cassel, et al.. (2005). Arylacetamide κ opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 15(10). 2647–2652. 11 indexed citations
15.
Bourdonnec, Bertrand Le, Catherine Goodman, Thomas M. Graczyk, et al.. (2005). Synthesis and structure–activity relationships of a new series of 2α-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as μ-selective opioid antagonists. Bioorganic & Medicinal Chemistry Letters. 16(4). 864–868. 2 indexed citations
16.
Bourdonnec, Bertrand Le, et al.. (2003). trans -3,4-Dimethyl-4-(3-carboxamidophenyl)piperidines: A novel class of μ-Selective opioid antagonists. Bioorganic & Medicinal Chemistry Letters. 13(24). 4459–4462. 23 indexed citations
17.
McCurdy, Christopher R., Bertrand Le Bourdonnec, Thomas G. Metzger, et al.. (2002). Naphthalene Dicarboxaldehyde as an Electrophilic Fluorogenic Moiety for Affinity Labeling:  Application to Opioid Receptor Affinity Labels with Greatly Improved Fluorogenic Properties. Journal of Medicinal Chemistry. 45(14). 2887–2890. 16 indexed citations
18.
Bourdonnec, Bertrand Le, Saı̈d Yous, Jean‐François Goossens, et al.. (2002). Comparison of 3D Structures and AT1 Binding Properties of Pyrazolidine-3,5-diones and Tetrahydropyridazine-3,6-diones with Parent Antihypertensive Drug Irbesartan. Journal of Medicinal Chemistry. 45(21). 4794–4798. 9 indexed citations
19.
Bourdonnec, Bertrand Le, Rachid El Kouhen, Gennady Poda, et al.. (2001). Covalently Induced Activation of the δ Opioid Receptor by a Fluorogenic Affinity Label, 7‘-(Phthalaldehydecarboxamido)naltrindole (PNTI). Journal of Medicinal Chemistry. 44(7). 1017–1020. 10 indexed citations
20.
Portoghese, Philip S., Rachid El Kouhen, Ping‐Yee Law, Horace H. Loh, & Bertrand Le Bourdonnec. (2001). Affinity labels as tools for the identification of opioid receptor recognition sites. Il Farmaco. 56(3). 191–196. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin E. Blass Breakdown of academic impact, for papers by Gregor J. Macdonald Breakdown of academic impact, for papers by José Ignacio Andrés Breakdown of academic impact, for papers by Mario Giannella Breakdown of academic impact, for papers by Hartmut E. Greiner Breakdown of academic impact, for papers by Andrew W. Stamford Breakdown of academic impact, for papers by Methvin Isaac Breakdown of academic impact, for papers by Kazumi Shiosaki Breakdown of academic impact, for papers by Kevin J. Hodgetts Breakdown of academic impact, for papers by О.А. Бунеева
Rankless by CCL
2026